Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01059019 · ClinicalTrials.gov registry record · NA
Epithelial Healing and Visual Outcomes Using Omega-3 Therapy Before and After Photorefractive Keratectomy (PRK) Surgery
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT01059019 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 17 participants.
The verdict
NCT01059019, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that omega-3 supplement can be use as an adjunct therapy for PRK patients. The investigators believe that omega-3 supplement will reduce the size of persistent epithelial defects (PEDS) and eventually hasten the corneal reepithelialization after PRK surgery. If the outcome of this study proves to be effective, then PRK would be a more attractive option to those seeking refractive treatment.
Interventions
- DIETARY_SUPPLEMENT Omega-3 Fatty Acid Supplements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2010-01 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01059019
The ClinicalTrials.gov registry entry for NCT01059019 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Omega-3 Fatty Acid Supplements is the first listed.
NCT01059019 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01059019 about?
NCT01059019 is a clinical study titled "Epithelial Healing and Visual Outcomes Using Omega-3 Therapy Before and After Photorefractive Keratectomy (PRK) Surgery". The purpose of this study is to demonstrate that omega-3 supplement can be use as an adjunct therapy for PRK patients. The investigators believe that omega-3 supplement will reduce the size of persistent epithelial defects (PEDS) and eventually hasten the corneal reepithelialization after PRK surger...
What is the current status of trial NCT01059019?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2010-01. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01059019?
The interventions under investigation include: Omega-3 Fatty Acid Supplements (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01059019?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.